MiMedx Group, Inc.

Total Valuation

MiMedx Group, Inc. carries a market capitalization of 666.13M, placing it among publicly traded companies globally. Its enterprise value stands at 442.41M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

MiMedx Group, Inc. currently has 145.72M shares outstanding.

Valuation Ratios

MiMedx Group, Inc. trades at a trailing price-to-earnings ratio of 91.39. The price-to-sales ratio is 1.61, and the price-to-book ratio stands at 2.60.

Enterprise Valuation

On an enterprise value basis, MiMedx Group, Inc. trades at an EV/EBITDA multiple of 21.68 and an EV/FCF ratio of 8.55. The EV/Sales ratio of 1.25 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 50.55 provides insight into valuation relative to core operating earnings.

Financial Position

MiMedx Group, Inc. maintains a current ratio of 5.33, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.97, indicating elevated leverage, while an interest coverage ratio of 50.77 demonstrates strong ability to service its debt obligations.

Financial Efficiency

MiMedx Group, Inc. posts a return on equity of 2.88 and a return on invested capital of 2.11.

Taxes

Over the trailing twelve months, MiMedx Group, Inc. has paid 5.29M in income taxes, reflecting an effective tax rate of 45.90.

Stock Price Statistics

MiMedx Group, Inc.'s stock has declined approximately -35.54302% over the past 52 weeks. The 50-day moving average sits at 4.24, while the 200-day moving average is 4.72.

Income Statement

Over the trailing twelve months, MiMedx Group, Inc. generated 355.17M in revenue and converted that into 6.24M in net income, yielding earnings per share of 0.04. EBITDA reached 20.41M, while operating income came in at 8.75M.

Balance Sheet

MiMedx Group, Inc. holds 135.84M in cash and equivalents against 17.21M in total debt, resulting in a net debt position of -118.63M. Total book value stands at 216.00M, with working capital of 166.87M providing operational flexibility.

Cash Flow

MiMedx Group, Inc. produced 46.15M in operating cash flow over the past twelve months. After subtracting -5.37M in capital expenditures, free cash flow totaled 40.78M - equivalent to 0.28 per share.

Margins

MiMedx Group, Inc. operates with a gross margin of 78.85, reflecting its pricing power and cost economics. The operating margin of 2.46 and net profit margin of 1.76 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

MiMedx Group, Inc.'s most recent stock split took place on April 2, 2008 with a 2000:647 split ratio.

Scores

MiMedx Group, Inc. posts an Altman Z-Score of 7.14, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.